文献速递胃肠外科围术期管理与 ERAS

家庭式预康复对胃癌术后并发症的影响:随机临床试验

Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial.
PubMed 文献 · Br J Surg · 2023-01-01

该随机临床试验在立陶宛两个中心纳入128例胃癌患者,1:1随机分为预康复组或标准护理组,评估个性化、多模式、半监督的家庭式预康复对术后90天内并发症的影响。结果显示预康复组术后并发症风险比降低(RR 0.40,95%CI 0.24-0.66),新辅助化疗不依从率降低(RR 0.20,95%CI 0.20-0.56),并改善生活质量。

要点

  • 家庭式预康复可降低胃癌手术后90天内并发症发生率(RR 0.40)。
  • 预康复组新辅助化疗不依从风险降低(RR 0.20)。
  • 预康复组术前6分钟步行试验较基线平均提高31米(95%CI 14-48,P=0.001)。

核心结论

  • 预康复降低了胃癌胃切除术患者的术后并发症发生率。

研究设计与样本

  • 随机临床试验,在立陶宛两个中心进行,128例胃癌患者按1:1随机分为预康复组(64例)或标准护理组(64例),最终分析122例(预康复组61例,对照组61例)。

主要发现

  • 预康复组术前6分钟步行试验较基线平均提高31米(95%CI 14-48,P=0.001)。
  • 预康复组新辅助治疗不依从风险比降低(RR 0.20,95%CI 0.20-0.56)。
  • 预康复组术后90天并发症患者数减少60%(RR 0.40,95%CI 0.24-0.66)。
  • 预康复组生活质量较对照组改善。

关键数值与推荐

  • 预康复组术后90天并发症风险比为0.40(95%CI 0.24-0.66)。
  • 预康复组新辅助化疗不依从风险比为0.20(95%CI 0.20-0.56)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies have demonstrated that prehabilitation improves patients' physical fitness but its impact on postoperative morbidity remains unclear. This study aimed to assess the effect of personalized, multimodal, semisupervised, home-based prehabilitation on postoperative complications after surgery for gastric cancer. METHODS: This RCT was conducted at two centres in Lithuania. Patients (aged at least18 years) with gastric cancer scheduled to undergo elective primary surgery or surgery after neoadjuvant chemotherapy for gastric cancer were randomized (1 : 1) to prehabilitation or standard care. Prehabilitation included exercise interventions focused on endurance, respiratory muscle strength, stretching, and resistance training as well as nutritional and psychological support. The primary outcome was the proportion of patients with postoperative complications within 90 days after surgery. Secondary outcomes included 90-day mortality rate, physical condition, fitness level, nutritional status, quality of life, anxiety and depression level, and proportion of patients completing neoadjuvant chemotherapy. RESULTS: Between February 2020 and September 2022, 128 participants were randomized to prehabilitation (64) or standard care (64), and 122 (prehabilitation 61, control 61) were analysed. The prehabilitation group had increased physical capacity before the operation compared with baseline (mean 6-min walk test change +31 (95 per cent c.i. 14 to 48) m; P = 0.001). The prehabilitation group had a decreased rate of non-compliance with neoadjuvant treatment (risk ratio (RR) 0.20, 95 per cent c.i. 0.20 to 0.56), a 60 per cent reduction in the number of patients with postoperative complications at 90 days after surgery (RR 0.40, 0.24 to 0.66), and improved quality of life compared with the control group. CONCLUSION: Prehabilitation reduced morbidity in patients who underwent gastrectomy for gastric cancer. REGISTRATION NUMBER: NCT04223401 (http://www.clinicaltrials.gov).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Bausys A, Luksta M, Anglickiene G, et al. Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial. Br J Surg. 2023. PMID: 37750588. doi:10.1093/bjs/znad312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。